PineBridge Investments’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-29,599
Closed -$7.27M 786
2022
Q3
$7.27M Buy
29,599
+29,522
+38,340% +$7.97M 0.09% 212
2022
Q2
$19K Buy
77
+2
+3% +$540 ﹤0.01% 677
2022
Q1
$25K Buy
+75
New +$23.1K ﹤0.01% 588
2021
Q3
Sell
-3,950
Closed -$1.23M 684
2021
Q2
$1.23M Sell
3,950
-13,297
-77% -$4.08M 0.01% 500
2021
Q1
$5.5M Buy
17,247
+17,151
+17,866% +$5.49M 0.07% 290
2020
Q4
$31K Sell
96
-126
-57% -$34.9K ﹤0.01% 606
2020
Q3
$62K Sell
222
-34
-13% -$9.79K ﹤0.01% 579
2020
Q2
$62K Sell
256
-115
-31% -$23.1K ﹤0.01% 562
2020
Q1
$54K Buy
371
+15
+4% +$2.49K ﹤0.01% 553
2019
Q4
$61K Sell
356
-3,516
-91% -$652K ﹤0.01% 913
2019
Q3
$689K Buy
3,872
+2,641
+215% +$571K 0.01% 833
2019
Q2
$321K Sell
1,231
-47,467
-97% -$12.6M 0.01% 776
2019
Q1
$13.9M Sell
48,698
-15,278
-24% -$5.08M 0.28% 101
2018
Q4
$20.8M Buy
63,976
+28,555
+81% +$9.92M 0.46% 62
2018
Q3
$15.9M Buy
35,421
+34,613
+4,284% +$13.6M 0.3% 94
2018
Q2
$330K Buy
+808
New +$293K 0.01% 766
2016
Q2
Sell
-4,768
Closed -$452K 1183
2016
Q1
$452K Sell
4,768
-470
-9% -$39.7K 0.02% 306
2015
Q4
$473K Buy
5,238
+458
+10% +$38.9K 0.02% 319
2015
Q3
$443K Buy
4,780
+451
+10% +$39.7K 0.02% 324
2015
Q2
$285K Sell
4,329
-5,162
-54% -$343K 0.01% 408
2015
Q1
$680K Buy
9,491
+1,202
+15% +$65.2K 0.03% 340
2014
Q4
$316K Buy
8,289
+369
+5% +$11.6K 0.01% 551
2014
Q3
$197K Buy
7,920
+2,394
+43% +$60.6K 0.01% 653
2014
Q2
$139K Sell
5,526
-3,366
-38% -$78.3K 0.01% 684
2014
Q1
$231K Sell
8,892
-551
-6% -$15.2K 0.01% 713
2013
Q4
$252K Buy
9,443
+5,449
+136% +$135K 0.01% 711
2013
Q3
$76K Hold
3,994
﹤0.01% 811
2013
Q2
$87K Buy
+3,994
New +$80.3K ﹤0.01% 751

Other funds holding ABMD

PineBridge Investments's ABMD Position: Q4 2022 in Review

PineBridge Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 29,599 shares — an estimated $7.27M sold.

PineBridge Investments first reported a position in ABMD in Q2 2013 and held it in 28 quarters. The position peaked at $20.8M in Q4 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • PineBridge Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • PineBridge Investments sold 29,599 Abiomed Inc shares in Q4 2022, an estimated $7.27M.
  • PineBridge Investments first reported a position in Abiomed Inc in Q2 2013 and held it in 28 quarters.
  • PineBridge Investments's Abiomed Inc position peaked at $20.8M in Q4 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on PineBridge Investments's 13F filing for Q4 2022, filed 9 Feb 2023.